Slow Repetitive TMS for Drug‐resistant Epilepsy: Clinical and EEG Findings of a Placebo‐controlled TrialRoberto Cantello, Paolo Maria Rossini, Anna Teresa Giallonardo et al.|Epilepsia|2007Cited by 181
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategiesPietro Iaffaldano, Giuseppe Lucisano, Francesca Caputo et al.|Therapeutic Advances in Neurological Disorders|2021Cited by 119
Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple SclerosisGiacomo Boffa, Alessio Signori, Luca Massacesi et al.|Neurology|2022Cited by 38
Transition to secondary progression in relapsing-onset multiple sclerosis: Definitions and risk factorsPietro Iaffaldano, Giuseppe Lucisano, Francesco Patti et al.|Multiple Sclerosis Journal|2020Cited by 32
JCPyV NCCR analysis in PML patients with different risk factors: exploring common rearrangements as essential changes for neuropathogenesisMaria Rosa Ciardi, Vincenzo Vullo, Maria Antonella Zingaropoli et al.|Virology Journal|2020Cited by 30